🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To evaluate the safety of 3 regimens of short-term, low-dose systemic IMT a...
Status
Withdrawn
Location
Wills Eye Institute
Start Date
2015-08-24
Trial ID
NCT02563782
The purpose of this study is to evaluate the long term safety and tolerabil...
Status
Completed
Location
Jules Stein Eye Institute, UCLA School of Medicine
Start Date
2012-07-11
Trial ID
NCT02445612
Treatments Being Tested
This is a safety and tolerability trial to evaluate the effect of subretina...
Status
Completed
Location
Jules Stein Eye Institute, UCLA School of Medicine
Start Date
2011-06-16
Trial ID
NCT01345006
Treatments Being Tested
The purpose of his study is to evaluate the long term safety and tolerabili...
Status
Completed
Location
Jules Stein Eye Institute, UCLA School of Medicine
Start Date
2013-02-25
Trial ID
NCT02463344
Treatments Being Tested
The purpose of this study is to evaluate the safety and tolerability of RPE...
Status
Completed
Location
CHA Bundang Medical Center
Start Date
2012-09
Trial ID
NCT01625559
Treatments Being Tested
To evaluate the safety and tolerability of MA09-hRPE cellular therapy in pa...
Status
Terminated
Location
CHA Bundang Medical Center
Start Date
2012-09
Trial ID
NCT01674829
Treatments Being Tested
This is a safety and tolerability trial to evaluate the effect of subretina...
Status
Completed
Location
Jules Stein Eye Institute, UCLA School of Medicine
Start Date
2011-06-09
Trial ID
NCT01344993
Treatments Being Tested
Pathologic myopia is a major cause of legal blindness worldwide. In myopic ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2013-03
Trial ID
NCT02122159
Treatments Being Tested
The purpose of this study is: To evaluate the safety and tolerability of R...
Status
Completed
Location
Lothian Health Board Headquarters at Waverley Gate
Start Date
2011-12-13
Trial ID
NCT01469832
Treatments Being Tested